compounded bioidentical menopausal hormone therapy pubmed ncbi abstract improvement long-term health longer indication menopausal hormone therapy evidence supporting fewer adverse events younger women combined high effectiveness reinforced usefulness short-term treatment menopausal symptoms menopausal therapy provided commercially products compounding creation individualized preparation response health care provider's prescription create medication tailored specialized individual patient women's health initiative findings coupled increase direct-to-consumer marketing media promotion compounded bioidentical hormonal preparations safe effective alternatives conventional menopausal hormone therapy led recent increase popularity compounded bioidentical hormones increase questions preparations evidence lacking support superiority claims compounded bioidentical hormones conventional menopausal hormone therapy claims pose additional risks variable purity potency lack efficacy safety data committee gynecologic practice american college obstetricians gynecologists practice committee american society reproductive medicine provide overview major issues concern surrounding compounded bioidentical menopausal hormone therapy provide recommendations patient counseling copyright num american society reproductive medicine published elsevier rights reserved 
